Hormone treatment and muscle anabolism during aging: androgens.
Aging is associated with a gradual decline in circulating testosterone concentrations and decreased musculature in men. While testosterone administration is often considered when symptoms of hypogonadism are presented, the long-term effects of androgen use on muscle physiology are not yet fully understood. The definition of hypogonadism in men remains obscure but is generally indicated by total testosterone concentrations less than a threshold value of 300-500 ng/dL. Androgen replacement therapy is generally safe in men and women with low endogenous testosterone concentrations. The development of selective androgen receptor modulators (SARMs) may provide additional options in treatment of hypogonadism while lowering the potential of side effects often associated with long-term androgen use. Androgen administration, either alone or in combination with other treatments, can be successful in improving muscle mass by increasing protein anabolism and reducing protein catabolism in men and women. Further research is necessary to optimize the anabolic and anticatabolic properties of androgens for treatment and prevention of muscle loss in men and women.
Dillon
E Lichar
EL
Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.
Durham
William J
WJ
Urban
Randall J
RJ
Sheffield-Moore
Melinda
M
D000375:Aging / Q000378:metabolism*; D000728:Androgens / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D011944:Receptors, Androgen / Q000187:drug effects; D013739:Testosterone / Q000008:administration & dosage / Q000627:therapeutic use
D000728:Androgens; D011944:Receptors, Androgen; D013739:Testosterone
J Sex Med. 2006 Nov;3(6):1085-1089
17100942
J Clin Endocrinol Metab. 1997 Feb;82(2):407-13
9024227
J Clin Endocrinol Metab. 2001 Feb;86(2):724-31
11158037
Am J Physiol. 1995 Nov;269(5 Pt 1):E820-6
7491931
Endocrinology. 2007 Jan;148(1):363-73
17023534
N Engl J Med. 1996 Jul 4;335(1):1-7
8637535
J Am Geriatr Soc. 2008 Nov;56(11):1991-9
18795988
Endocrinology. 2007 Jan;148(1):1-3
17179140
Ann Surg. 2007 Sep;246(3):351-60; discussion 360-2
17717439
Acta Physiol (Oxf). 2009 Apr;195(4):471-82
18801052
J Clin Endocrinol Metab. 2009 Dec;94(12):4776-84
19846742
J Clin Endocrinol Metab. 2002 Apr;87(4):1550-4
11932280
Nucl Recept Signal. 2008;6:e010
19079612
J Clin Endocrinol Metab. 2008 Aug;93(8):3066-74
18477661
J Gerontol A Biol Sci Med Sci. 2003 Nov;58(11):1002-8
14630881
Nat Clin Pract Endocrinol Metab. 2006 Mar;2(3):146-59
16932274
J Clin Endocrinol Metab. 2006 Oct;91(10):3844-9
16895962
Eur J Endocrinol. 2009 Nov;161(5):795-8
19749027
Fertil Steril. 2008 Nov;90(5 Suppl):S83-7
19007654
J Trauma. 2009 Apr;66(4):1083-90
19359918
Mol Cell Endocrinol. 2009 Apr 10;302(1):26-32
19356623
Maturitas. 2008 Sep-Oct;61(1-2):17-26
19434876
J Clin Endocrinol Metab. 2006 Jan;91(1):136-44
16263817
J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010
16720669
J Clin Endocrinol Metab. 1992 Oct;75(4):1092-8
1400877
FASEB J. 2009 Feb;23(2):631-41
18827019
Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E506-16
16621900
Am J Clin Nutr. 2009 Mar;89(3):880-9
19144729
J Clin Endocrinol Metab. 2006 Aug;91(8):3024-33
16705073
J Endocrinol. 2001 Jul;170(1):27-38
11431134
J Immunol. 1999 Jan 1;162(1):35-40
9886367
Maturitas. 2009 Jan 20;62(1):76-80
19108962
N Engl J Med. 2004 Jan 29;350(5):440-2
14749451
Fertil Steril. 2002 Apr;77(4):660-5
11937111
J Clin Endocrinol Metab. 2001 Jun;86(6):2369-72
11397825
J Clin Endocrinol Metab. 2007 Feb;92(2):509-16
17090636
Maturitas. 2009 May 20;63(1):63-6
19250779
Exp Gerontol. 2006 Dec;41(12):1234-8
17052879
J Clin Endocrinol Metab. 2000 Jan;85(1):66-70
10634365
J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):618-25
12865477
Endocrinology. 2008 Apr;149(4):1987-93
18096666
J Pediatr. 2009 Nov;155(5):714-20
19643440
Endocrinology. 2008 Nov;149(11):5449-60
18599544
J Clin Endocrinol Metab. 2004 Jul;89(7):3313-8
15240608
J Clin Endocrinol Metab. 2000 Aug;85(8):2670-7
10946864
J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710
17018650
Exp Gerontol. 2006 Nov;41(11):1136-48
17064867
J Strength Cond Res. 2007 May;21(2):354-61
17530941
Adv Physiol Educ. 2008 Jun;32(2):120-6
18539850
Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E601-7
11832363
J Bone Miner Res. 2007 Jan;22(1):72-82
17014385
J Clin Endocrinol Metab. 2009 Jun;94(6):1991-2001
19293261
BJU Int. 2010 May;105(10):1397-401
19912179
Pituitary. 2009;12(2):116-24
18421580
J Sex Med. 2009 Mar;6(3):777-90
19207276
J Clin Endocrinol Metab. 2006 Feb;91(2):477-84
16332938
Biochem Biophys Res Commun. 2007 Sep 14;361(1):237-42
17658471
J Steroid Biochem Mol Biol. 2008 May;110(1-2):125-9
18436443
Eur J Endocrinol. 2009 Apr;160(4):681-7
19174532
Hum Reprod. 2009 Sep;24(9):2276-85
19520711
J Gerontol A Biol Sci Med Sci. 2001 May;56(5):M266-72
11320105
J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):243-8
19182229
J Immunol. 2001 Aug 15;167(4):2060-7
11489988